Skip to main content
. Author manuscript; available in PMC: 2018 Oct 14.
Published in final edited form as: Am J Drug Alcohol Abuse. 2018 Apr 19;44(4):488–496. doi: 10.1080/00952990.2018.1458234

Figure 4.

Figure 4.

Schematic representation or primary results of the linear latent growth model of opioid-positive urinalysis (opioid+UA) over time in a randomized clinical trial that compared buprenorphine/naloxone tapering strategies (7-day and 28-day) in the male sample. Unstandardized regression coefficients are reported. ASI-L = Addiction Severity Index-Lite; *p<.05; ns statistically non-significant.